Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shimura

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
American Journal of Hematology|July 14, 1998
Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuriesH Wada, Y Mori, M Shimura, et al.
American Journal of Hematology|April 1, 1996
Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulationH Wada, Y Wakita, T Nakase, et al.
American Journal of Hematology|April 15, 1999
Hemostatic molecular markers before the onset of disseminated intravascular coagulationH Wada, N Sakuragawa, Y Mori, et al.
Oncogene|September 20, 2006
HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombinationC Nakai-Murakami, M Shimura, M Kinomoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2024
Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profilingL Goyal, D DiToro, A Hollebecque, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 5, 1998
Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapyY Sakane, H Wada, H Kazuyo, et al.
American Journal of Hematology|August 1, 1997
Increased tissue factor pathway inhibitor in patients with acute myocardial infarctionY Kamikura, H Wada, A Yamada, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulationM Yamamuro, H Wada, K Kumeda, et al.
American Journal of Hematology|August 10, 1999
Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery diseaseY Saito, H Wada, M Yamamuro, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 25, 2000
Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysisA Inoue, H Wada, M Takagi, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
American Journal of Hematology|July 14, 1998
Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuriesH Wada, Y Mori, M Shimura, et al.
American Journal of Hematology|April 1, 1996
Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulationH Wada, Y Wakita, T Nakase, et al.
American Journal of Hematology|April 15, 1999
Hemostatic molecular markers before the onset of disseminated intravascular coagulationH Wada, N Sakuragawa, Y Mori, et al.
Oncogene|September 20, 2006
HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombinationC Nakai-Murakami, M Shimura, M Kinomoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2024
Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profilingL Goyal, D DiToro, A Hollebecque, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 5, 1998
Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapyY Sakane, H Wada, H Kazuyo, et al.
American Journal of Hematology|August 1, 1997
Increased tissue factor pathway inhibitor in patients with acute myocardial infarctionY Kamikura, H Wada, A Yamada, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulationM Yamamuro, H Wada, K Kumeda, et al.
American Journal of Hematology|August 10, 1999
Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery diseaseY Saito, H Wada, M Yamamuro, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 25, 2000
Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysisA Inoue, H Wada, M Takagi, et al.
Pageof 11